Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Princiotta

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Immunity|April 16, 2004
Proteasomes get by with lots of help from their friendsJonathan W Yewdell, Michael F Princiotta
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2013
Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathwayBenjamin J Wolf, Michael F Princiotta
Molecular Immunology|November 12, 2010
Viral and bacterial minigene products are presented by MHC class I molecules with similar efficienciesBenjamin J Wolf, Michael F Princiotta
Blood|June 30, 2012
All roads lead to "ome": defining the DRiPomeJonathan W Yewdell, Michael F Princiotta
The Journal of Biological Chemistry|November 3, 2005
Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality controlShu-Bing Qian, Michael F Princiotta, Jack R Bennink, et al.
Plos One|May 15, 2013
γδ T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a Listeria model of infection independently of CD28 costimulationRenee M Laird, Benjamin J Wolf, Michael F Princiotta, et al.
Journal of Neuroimmunology|February 16, 2005
Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generationMary E Truckenmiller, Michael F Princiotta, Christopher C Norbury, et al.
Immunohorizons|December 4, 2019
Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late ProteinsTing Kuang Niu, Michael F Princiotta, Janet J Sei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2013
Connexin43 is dispensable for phagocytosisAaron M Glass, Benjamin J Wolf, Karin M Schneider, et al.
Expert Review of Vaccines|December 9, 2021
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapyGuilhem Richard, Michael F Princiotta, Dominique Bridon, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Immunity|April 16, 2004
Proteasomes get by with lots of help from their friendsJonathan W Yewdell, Michael F Princiotta
Journal of Immunology (Baltimore, Md. : 1950)|February 12, 2013
Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathwayBenjamin J Wolf, Michael F Princiotta
Molecular Immunology|November 12, 2010
Viral and bacterial minigene products are presented by MHC class I molecules with similar efficienciesBenjamin J Wolf, Michael F Princiotta
Blood|June 30, 2012
All roads lead to "ome": defining the DRiPomeJonathan W Yewdell, Michael F Princiotta
The Journal of Biological Chemistry|November 3, 2005
Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality controlShu-Bing Qian, Michael F Princiotta, Jack R Bennink, et al.
Plos One|May 15, 2013
γδ T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a Listeria model of infection independently of CD28 costimulationRenee M Laird, Benjamin J Wolf, Michael F Princiotta, et al.
Journal of Neuroimmunology|February 16, 2005
Corticosterone impairs MHC class I antigen presentation by dendritic cells via reduction of peptide generationMary E Truckenmiller, Michael F Princiotta, Christopher C Norbury, et al.
Immunohorizons|December 4, 2019
Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late ProteinsTing Kuang Niu, Michael F Princiotta, Janet J Sei, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 5, 2013
Connexin43 is dispensable for phagocytosisAaron M Glass, Benjamin J Wolf, Karin M Schneider, et al.
Expert Review of Vaccines|December 9, 2021
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapyGuilhem Richard, Michael F Princiotta, Dominique Bridon, et al.
Pageof 3